Analisis Jenis Leukosit Pada Penderita Tuberkulosis yang Menjalani Pengobatan dengan Obat Anti Tuberkulosis di Kota Bengkulu
DOI:
https://doi.org/10.33088/jmk.v17i2.1162Keywords:
Obat anti tuberkulosis, Leukosit, TuberkulosisAbstract
Tuberculosis is a disease in Indonesia that has received special attention from the Ministry of Health. Tuberculosis is a deadly infectious infectious disease, this is because Mycobacterium Tuberculosis has infected the world's population. Transmission of tuberculosis can be through droplets during coughing or sneezing and can infect other healthy people. Tuberculosis patients receive routine treatment with Anti-Tuberculosis Drugs. In the process, this drug has an effect on the number of leukocytes which previously increased in number due to infection and the presence of antibodies that bind to the leukocyte cell membrane causing lysis of leukocyte cells. Checking the number of leukocytes is useful as a diagnostic basis because it can describe the occurrence and process of the disease in the body of tuberculosis patients. The purpose of this study is to describe the characteristics of tuberculosis patients based on gender and age, describe the type of leukocytes of patients who received anti-tuberculosis drug treatment during the May-July 2024 period in the Bengkulu City area. In this study, a research design with a cross sectional descriptive method was used to see the characteristics of leukocytes during tuberculosis patients receiving treatment with anti-tuberculosis drugs. The samples used were tuberculosis patients who were receiving anti-tuberculosis drug treatment in the work area of the Nusa Indah Health Center, Bengkulu City. Patients will have their blood samples taken for analysis of their leukocytes without looking at the identity of the treatment period. The results of the count of basophils, eosinophils, rod neutrophils and monocytes showed normal values, while the results of the count of segment neutrophils, lymphocytes, leukocytes were found in some patients with abnormal values. This is possible because the anti-tuberculosis drugs taken can reduce the number of leukocytes that increase at the time of infection and in some patients are abnormal because it is still in the early stages of treatment.
Downloads
References
Alamlih, L. et al. (2020) ‘Hematologic Characteristics of Patients with Active Pulmonary, Extra-Pulmonary and Disseminated Tuberculosis: A Study of over Six Hundred Patients’, Journal of Tuberculosis Research, 08(02), pp. 33–41. doi:10.4236/jtr.2020.82004.
Aprilia, A., Hidriya, H. and Risnawati, R. (2023) ‘Gambaran Jumlah Limfosit Pada Penderita Tuberkulosis Paru Yang Mendapat Terapi Obat Anti Tuberkulosis (OAT) Di Puskesmas Pekauman Kota Banjarmasin’, JEMPOL : Jurnal Elektronik Mahasiswa Polanka, 1(1), pp. 38–45. doi:10.52674/jmpl.v1i1.86.
Borkute, R.R. et al. (2021) ‘Neutrophils in tuberculosis: Cell biology, cellular networking and multitasking in host defense’, International Journal of Molecular Sciences, 22(9). doi:10.3390/ijms22094801.
Darmawansyah and Wulandari (2021) ‘Hubungan Tingkat Pengetahuan Dengan Kejadian Tb Paru Di Wilayah Kerja Puskesmas Padang Serai Kota Bengkulu’, Journal of Nursing and Public Health, 9(2), pp. 18–22. doi:10.37676/jnph.v9i2.1790.
Dina, D., Zaini, M. and Yahya, Y. (2019) ‘Gambaran Pemeriksaaan Hapusan Darah Tepi Diffcount (Sel Limfosit) Pada Penderita TBC Di Puskesmas Kelayan Timur Banjarmasin’, Jurnal Kajian Ilmiah Kesehatan dan Teknologi, 1(2), pp. 34–38. doi:10.52674/jkikt.v1i2.8.
Fauziah, I., Karim, A. and Lubis, M.N.F. (2021) ‘Analisa jenis dan jumlah sel leukosit pada penderita tuberculosis yang menjalani pengobatan obat anti tuberculosis selama 2 bulan di Rumah Sakit Khusus Paru Medan’, Medan, pp. 1–46. Available at: http://repository.uma.ac.id/handle/123456789/15704.
Kemenkes (2016) ‘Penanggulangan Tuberculosis’.
Kirwan, D.E., Chong, D.L.W. and Friedland, J.S. (2021) ‘Platelet Activation and the Immune Response to Tuberculosis’, Frontiers in Immunology, 12(May), pp. 1–11. doi:10.3389/fimmu.2021.631696.
Magne, J., Guy, J. and Maynadié, M. (2015) Hematology, Revue Francophone des Laboratoires. doi:10.1016/S1773-035X(15)30080-0.
Maulidiyanti, E.T.S. (2020) ‘Status Kadar Hemoglobin Dan Jenis Leukosit Pada Pasien TB Paru Di Surabaya’, the Journal of Muhammadiyah Medical Laboratory Technologist, 3(1), p. 53. doi:10.30651/jmlt.v3i1.4013.
Nasution, Elfira and Faswita, & (2023) Pencegahan Penularan Tuberkulosis Paru, Eureka Media Aksara, Juni 2023 Anggota Ikapi Jawa Tengah No. 225/Jte/2021. Available at: https://medium.com/@arifwicaksanaa/pengertian-use-case-a7e576e1b6bf.
Purwaeni, P. (2020) ‘Perbandingan Jumlah Leukosit Pada Penderita Tuberkulosis Sebelum Dan Sesudah Pengobatan Obat Anti Tuberkulosis Fase …’, Jurnal Kesehatan Rajawali, 10(2), pp. 84–94. Available at: http://ojs.rajawali.ac.id/index.php/JKR/article/view/61.
Sampath, P. et al. (2018) ‘Monocyte Subsets: Phenotypes and Function in Tuberculosis Infection’, Frontiers in Immunology, 9(July), pp. 1–8. doi:10.3389/fimmu.2018.01726.
Sari, M. (2021) ‘Terapi Tuberkulosis’, Jurnal Medika Hutama, 03(01), pp. 1571–1575.
Sihombing, J.R. and Ritonga, A.H. (2015) ‘Pemeriksaan Jumlah Presentase Sel Monosit Pada Penderita Tuberculosis Paru Di Upt Kesehatan Provinsi Sumatera Utara’, Jurnal Kesehatan Masyarakat dan Lingkungan Hidup, pp. 422–433. Available at: http://e-journal.sari-mutiara.ac.id/index.php/ALM/article/view/788.
